1. 514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience. (4th December 2021) Authors: Belden, Katherine; Hess, Bryan; Brugger, Caroline; Carr, Rachel; Braun, Todd; DeRose, Joseph L; Zurlo, John Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 514. Anti-SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real World Experience. (4th December 2021) Authors: Belden, Katherine; Hess, Bryan; Brugger, Caroline; Carr, Rachel; Braun, Todd; DeRose, Joseph L; Zurlo, John Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti–SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real-World Experience. Issue 2 (27th March 2022) Authors: Belden, Katherine A.; Hess, Bryan; Brugger, Caroline; Carr, Rachel; Braun, Todd; DeRose, Joseph; Zurlo, John Journal: Infectious diseases in clinical practice Issue: Volume 30:Issue 2(2022) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti–SARS-CoV-2 Monoclonal Antibodies for Early COVID-19: A Real-World Experience. Issue 2 (March 2022) Authors: Belden, Katherine A.; Hess, Bryan; Brugger, Caroline; Carr, Rachel; Braun, Todd; DeRose, Joseph; Zurlo, John Journal: Infectious diseases in clinical practice Issue: Volume 30:Issue 2(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗